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Abstract
Background:  Progress in automated image analysis, virtual microscopy, hospital information systems, and
interdisciplinary data exchange require image standards to be applied in tissue-based diagnosis.
Aims: To describe the theoretical background, practical experiences and comparable solutions in other medical fields
to promote image standards applicable for diagnostic pathology.
Theory and experiences: Images used in tissue-based diagnosis present with pathology – specific characteristics. It
seems appropriate to discuss their characteristics and potential standardization in relation to the levels of hierarchy in
which they appear. All levels can be divided into legal, medical, and technological properties. Standards applied to the first
level include regulations or aims to be fulfilled. In legal properties, they have to regulate features of privacy, image
documentation, transmission, and presentation; in medical properties, features of disease – image combination, human –
diagnostics, automated information extraction, archive retrieval and access; and in technological properties features of
image acquisition, display, formats, transfer speed, safety, and system dynamics. The next lower second level has to
implement the prescriptions of the upper one, i.e. describe how they are implemented. Legal aspects should demand
secure encryption for privacy of all patient related data, image archives that include all images used for diagnostics for a
period of 10 years at minimum, accurate annotations of dates and viewing, and precise hardware and software
information. Medical aspects should demand standardized patients' files such as DICOM 3 or HL 7 including history and
previous examinations, information of image display hardware and software, of image resolution and fields of view, of
relation between sizes of biological objects and image sizes, and of access to archives and retrieval. Technological aspects
should deal with image acquisition systems (resolution, colour temperature, focus, brightness, and quality evaluation
procedures), display resolution data, implemented image formats, storage, cycle frequency, backup procedures,
operation system, and external system accessibility. The lowest third level describes the permitted limits and threshold in
detail. At present, an applicable standard including all mentioned features does not exist to our knowledge; some aspects
can be taken from radiological standards (PACS, DICOM 3); others require specific solutions or are not covered yet.
Conclusion: The progress in virtual microscopy and application of artificial intelligence (AI) in tissue-based diagnosis
demands fast preparation and implementation of an internationally acceptable standard. The described hierarchic order
as well as analytic investigation in all potentially necessary aspects and details offers an appropriate tool to specifically
determine standardized requirements.
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Introduction
Tissue-based diagnosis is considered to be the most accu-
rate and, in addition, inexpensive diagnostic technique in
medicine. It is subject to considerable changes in respect
to implementation of newly developed technologies.
These comprise two main fields, namely molecular biol-
ogy tools including molecular genetics, as well as digital
information acquisition and distribution [1-4]. Telepa-
thology, which is the transfer and viewing of macroscopic
and microscopic images at a distance, served as the main
promoter in developing the digitalization of histological
glass slides and viewing microscopic images on a TV
screen [5-10]. It was fully established in the early 1990s
and was followed by the construction of specific telemed-
icine systems such as the iPATH or UICC-TPCC at the
beginning of this century [11,12]. At present digitalization
of a complete glass slide is commercially available as well
as internet – accessible automated measurement systems
such as EAMUS™ [13,14].
Diagnosis of radiological images obtained from compu-
terized tomography (CT) or magnetic nuclear resonance
(MR) underwent comparable changes too: the viewing of
radiological films has been replaced by viewing com-
pletely digitized radiological images. These changes have
been remarkably promoted by its expense savings over
conventional film, its development, and environmental
considerations in reducing the pollution induced by film
development by-products [15-18]. The technology has
been matured, and spatially completely distributed diag-
nostics are offered that separate the diagnostic work with
the patient (CT, MR imaging, etc.) at the hardware locali-
zation from viewing the images by radiologists and, in
addition, from typing the radiologists' dictations at a dif-
ferent, third, location by secretaries [19,17,20,18]. Ade-
quate standards of image acquisition, interaction with the
hospital information system and data documentation
have been implemented contemporarily with this devel-
opment [21]. Picture Archiving and Computation System
(PACS) and the DICOM standard have to be mentioned
herein [19]. These regulations and internationally
accepted standards are nearly missing in diagnostic
pathology to our knowledge. There exist recommenda-
tions and regulations of laboratory practice which are
included in the Code of Federal Regulations (CFR) of the
United States of America as well as those mentioned in
Good Laboratory Practice (GLP), and veterinary patholo-
gists have stated a toxicologic pathology position paper
on pathology image data (regulatory forum). Whether
these recommendations can be transferred into human
diagnostic pathology still remains an open question.
The same consideration holds true when taking a closer
look at the working conditions of radiology and diagnos-
tic pathology: Digital images acquired from histological
slides are in use for medical diagnosis in a similar manner
compared to radiological images; however, the specific
conditions differ at least in image nature (black and white
versus colour) and clinical environment (radiological
images have to be viewed by clinicians working in differ-
ent disciplines too, for example by surgeons, whereas the
judgement of microscopic images completely remains a
domain of surgical pathologists).
In this article we analyze the theoretical background and
recent developments of microscopic image analysis and
preposition to work out appropriate standards. A basic
scheme of three different levels in a hierarchic order each
consisting of three different "columns" (legal, medical,
technological) is suggested. In addition, we want to pro-
vide tools that can serve to successfully implement such
standards in the daily practice of virtual microscopy in
terms of distributed and interdisciplinary medical infor-
mation transfer.
Definition of internal standards, workflow in diagnostic 
pathology and virtual microscopy
Human diagnostics
A standard to be useful in tissue-based diagnosis has to
fulfill all conditions that permit an easy and reliable gen-
eration, distribution and access to patient – oriented med-
ical information [22-24,7,25-29]. In addition, it has to
supervise all steps of medical information created in and
distributed by an institute of pathology. Thus, the aim is
to define prescriptions and their appropriate use to permit
individual diagnostics without taking care of specific
influences that might be necessary for this process or, on
the other hand, might disturb or hinder an effective work.
The starting point of such an information handling and
distributing system is the laboratory work that necessarily
has to separate the tissue from the patient. The mandatory
unequivocal attachment of tissue and patient is com-
monly performed by using bar codes that permit distrib-
uted laboratory work without losing the connection to the
focus point, i.e. the patient. Theoretically, different
approaches could be performed too, such as unique clas-
sification of colour, size, and appearance of the submitted
tissue similar to a finger print; DNA analysis of the tissue
prior to further processing, etc. The creation of an ID
number allows tissue processing, production of glass
slides, diagnostics and creation of the final, patient – ori-
ented report, independently of how many and what kind
of glass slides, dictations, etc. are involved [22,30-32].
The workflow in an institute of pathology usually follows
a time sequence order of tissue identification (creation of
ID number), tissue processing and slide production,
patient – oriented diagnostics, secretary work, diagnosis
submission to the clinician, and financial aspects (reim-Diagnostic Pathology 2008, 3:17 http://www.diagnosticpathology.org/content/3/1/17
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bursement). The described workflow is not a simple
straightforward procedure. In contrast, there might be sev-
eral feedback mechanisms necessarily included between
glass slide production and final diagnosis. They are
induced by mandatory additional stains and external
information sources. The patient-oriented diagnostics are
critical points of external information influence either
going straight forward or opening the feedback mecha-
nisms.
The feedback pathways are opened if a) slide quality is
poor, b) crude viewing or c) external (clinical) informa-
tion suggests additional laboratory investigations. As vir-
tual microscopy replaces only the conventional viewing
via a microscope the basics of the described work flow
remain the same. However, virtual microscopy offers the
chance to interact with all feedback mechanisms directly.
For example, it can order additional necessary laboratory
work prior to the pathologist's diagnosis.
Obviously, the described work flow depends upon thresh-
olds that trigger the described pathways. The triggering
thresholds depend upon values that are defined by the
proposed first level of standards, namely:
a) Legal: Which quality can be tolerated without suing the
pathologist in case of errors?
b) Medical: Which quality and information compound
still permit a reliable diagnosis?
c) Technological: How can quality be measured? Which
quality can be automated, monitored, and corrected (or
replaced)?
It is quite difficult to answer these questions, especially as
the term "quality" depends upon the diagnosis under con-
sideration: Simple and frequently stated diagnoses require
less "quality" when compared with difficult or rare diag-
noses. Thus, the threshold of "good image quality" has to
be adjusted to the unknown outcome or the "final and
correct diagnosis".
Selecting appropriate or diagnosis – relevant fields of view
is an additional task of a diagnostic pathologist. What is a
diagnosis – relevant field of view? The easiest answer is to
view the complete electronic image and document all
fields of view in combination with the chosen magnifica-
tion, image brightness, and focus.
On the other hand, constant image quality levels can be
introduced if the inductive term "diagnosis" is disre-
garded, and only image measurements are under consid-
eration. To our knowledge, image measurement and
quality standards do exist for static quantitative DNA
analysis only [33-37]. The standards permit a standard
deviation of 3% when measuring the DNA content (inte-
grated optical density) of Feulgen stained nuclei in cyto-
logical smears [38,35,28]. These limits can be controlled
by the internet accessible server "EUROQUANT" which
can work on both static DNA quantification systems and
the performance of laboratory Feulgen stains [38].
Machine diagnostics
The development of artificial intelligence and its introduc-
tion to virtual microscopy will affect the diagnostic work
of a pathologist too. The establishment of distributed tis-
sue-based diagnosis networks will probably occur in a
Grid environment and will sooner or later implement
automated diagnostic procedures [39,13,2-4]. The imple-
mentation will certainly require appropriate standards,
which again can be attributed to legal, medical and tech-
nological necessities.
Legal aspects primarily have to deal with protection of the
patient's privacy in a distributed electronic network.
Secure encryption techniques have been developed; how-
ever, the legal limits of quantitative probability measures
to break such a system are still missing to our knowledge.
For example, the maximum time allowance to work out
an individual diagnosis has not been defined. Obligatory
quality assurance by (expert) consultation does not exist
as well. Archives have to ensure correct encryption of diag-
nosis for at least ten years in comparison to glass slide
archives. DNA characteristics should be encrypted too.
Images used for diagnostic aims have to be labelled. The
label should indicate that the image served for diagnostic
purposes and also include diagnostic specificities such as
primary diagnosis, expert consultation, or measurement.
These legal standards have to cover the internal work flow
of each individual pathology institution.
Medical aspects are associated with the diagnostic proce-
dure and related to the applied diagnostic algorithms. The
main issues include permitted levels of diagnosis to be
automatically stated or the characteristics and number of
biological units that are necessary to state a diagnosis,
their displayed structures, and the analysis of underlying
tissue texture [2,40,41]. These terms direct to terms of tis-
sue screening (cancer versus inflammation versus normal
tissue?), or to features such as minimum number of pixels
to build a biological unit (for example nucleus, cell,
gland, vessel, etc.), or minimum pixel size of the whole
image in relation to the tissue texture. Standards of expert
consultation and assurance of diagnostic sensitivity and
specificity have to take into account the level and diffi-
culty of diagnosis under consideration. It seems to be
more appropriate (and practical) to investigate more fre-
quently and more in detail in difficult diagnoses than just
to cover general terms such as invasive ductal breast carci-Diagnostic Pathology 2008, 3:17 http://www.diagnosticpathology.org/content/3/1/17
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noma. Teaching and continuous education standards of
an automated diagnosis system should not be forgotten as
probably the future system will be of a flexible, self adjust-
ing and self organization nature [2,3,14].
Technological aspects are related to the aims of the system
or network. In radiology, the well known image archiving
standard PACS (Picture Archiving and Communication
Systems or PAC systems) manages the creation, distribu-
tion, and archiving of digital images. It can still be consid-
ered as the "internal standard" as it has been specifically
developed for diagnostic live imaging. It usually consists
of image acquisition and archive devices, as well as diag-
nostic workstations embedded in a network with reason-
able bandwidth, and archive device archive/routing
software. The bandwidth is important as radiological
images usually comprise 10 – 50 Megabytes per study. All
modern PAC systems use the DICOM standard and
include a network protocol that runs on top of the existing
internet standard protocol (TCP/IP).
Some efforts have been made to include or appropriate
adjust the PACS and DICOM standard to the needs of
diagnostic pathology [42-46,29]. When designed for the
needs of virtual microscopy they have to include hardware
and software features. Nature and number of included
nodes in a network, interconnectivity, computation veloc-
ity, backup procedures, information acquisition, distribu-
tion, and display have to be defined in appropriately
ranges. System reaction in case of data overload must be
included as well as boundaries in computation power
[47,24,48,49,46]. The acknowledged standard of such a
system should be considered as "internal" and not as
"external" or for communicative standards.
Communicative standards
Basics
Progress in diagnostic medicine is mainly related to
acquiring, viewing, and distributing images obtained
from a broad variety of sources. When introducing digital
images into medical diagnostics it was soon recognized
that standards are essential if images produced by equip-
ment of company A should be compared with those of
company B, or if images of different origin such as CT,
ultrasound, or endoscopy should be "prepared to one case
only". For these purposes the so-called DICOM standard
has been released in the late 1980s followed by DICOM 3
in 1993. The acronym, DICOM stands for Diagnostic
Images and Communication in Medicine. DICOM 3.0 is now
universally respected and acknowledged as international
standard. DICOM standardized images contain much
more information than the basic image. They possess
"standardized" headers that permit identifying the
patient, details of image acquisition and processing (for
example, whether the image is unaltered or "enhanced")
[50]. Several working groups deal with the application of
DICOM standards in specific medical disciplines, and the
working group 26 (WG 26) has been established to pro-
pose a common appropriate model for combining both
HL 7 and DICOM 3 in tissue-based diagnosis [43].
Legal aspects
They include those stated for internal standardization
such as patient's privacy, labelling of transferred images,
date and time schedules as well as notification of image
properties in order to avoid mistakes.
Medical aspects
In addition to the internal standards, reasons for commu-
nication and transfer of medically important information
are required. The reasons of specific area selection should
be documented when submitting still images. The
number of transmitted still images, the chosen magnifica-
tion, and specific stains should be noted. The standards
should be adjusted to the clinical diagnosis. In general, an
average number of 4–6 images, acquired by at least 2 dif-
ferent magnifications, can be considered as baseline
[3,25]. Images acquired from H & E stained slides are
essential, those from adequate immunohistochemical
procedures usually helpful [3,25]. These recommenda-
tions derive from telepathology experiences
[51,6,52,53,49,46]. Tissue micro arrays (TMA) should be
included in these recommendations despite they fre-
quently serve for scientific investigations only [54,55].
Technological aspects
Recommendations for adequate standards are related to
data security, transfer speed, reliability of data transmis-
sion, and stability of line connections, and aspects of
image compression [47,56-58,46]. In addition, techno-
logical standards that regulate adequate signal release and
receipt with correct understanding such as IEEE 802.11, a
standard family for wireless local area network (WLAN),
are essential. The general implementation of the internet
and cellular phones has extensively promoted and imple-
mented general available communication protocols and
standards [59]. However, they need to be adjusted to the
specific conditions of tissue-based diagnosis.
Considerations image acquisition, and graphical 
presentation of virtual slides
It is a primary requirement that pathologists should be
provided with sufficiently high-quality images for carry-
ing out effective diagnoses.
Histological images are commonly acquired by attaching
several frames of an image, and to automatically compose
a wide field of view and high resolution image from these
frames. The final image consists of several attached digital
image mosaics (patchwork). The jagged images then needDiagnostic Pathology 2008, 3:17 http://www.diagnosticpathology.org/content/3/1/17
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smoothness for correct presentation. The generated
images or virtual slides are always available as Bitmaps.
The electronic presentation of virtual slides depends upon
the image acquisition system, the optical resolution in
comparison to the capabilities of the human eye (to be
assumed one micron), and the light colour balance in
order to display the colours as truly as possible. The
pathologist wants to view and manipulate virtual slides in
the same way he is handling the light microscope. There-
fore, the mandatory image processing is a key point and
has to leverage signal-processing capabilities developed in
other scientific fields. Afterwards, image archiving and
retrieving is more or less a matter of available information
technologies.
The necessary image processing is related to signal-
processing in general and coordinates features of image
acquisition, transfer and display. In addition to specific
algorithms, architectures for image coding, filtering, resto-
ration, segmentation, colour reproduction and display,
the image size is of major significance.
Image size refers to the physical dimensions of an image,
and is usually based upon a fixed number of pixels.
Increasing the size of an image decreases its resolution,
and decreasing its size increases its resolution. Image res-
olution refers to the spacing of pixels in an image. The
higher the resolution, the more pixels form the image.
Higher resolution allows for more detail and subtle colour
transitions in an image.
The display of an acquired image (virtual slide) is the tool
the pathologist is working with. Its optical resolution is
expressed in pixels per square inch; (e.g. 600 dpi dots per
inch; a 22 inch screen can present 9 million pixels). The
precision and the colour truth of the pixels contribute to
the displayed image quality too. Therefore, the size of the
screen, the number of pixels the screen can display, the
brightness of the screen (measured in Lumen), the con-
trast ratio (e.g. 2000:1), and the colour depth expressed in
bits to represent each colour (e.g. 24 bit RGB) are a matter
of technological image standard. In practice, the screen
resolution depends on the technology chosen and include
SVGA 800*600, or XGA 1024*768, or SXGA 1280*1024
as the most recent technology available.
Level of standards to be applied in tissue-based diagnosis
Standards should permit constancy in work performance
as well as in information release and receipt
[22,23,60,15,6]. In addition, they should assure a certain
quality level. Introducing standards in tissue-based diag-
nosis has to overcome several constraints. These include
conservative behaviour of pathologists, fears of additional
costs, regulations by external institutions, and commonly
missing technological knowledge. We therefore propose
three hierarchical levels of standards in order to demon-
strate the nature and potential effects in the daily work of
a surgical pathologist. The levels are listed in table 1.
The first level (level 1) provides information about the
included standardization aspects. It "triggers" the next
(second) level, and is comparable to the labels of an
archive system. Level two generates the necessary items to
be standardized, and level three contains the actual data
(permitted thresholds or limits). The "columns" at each
level are independent from each other. Thus, technologi-
cal development can be included without changing the
legal or medical positions, and vice versa.
Grading standards into a proposed level ensures flexibility
and introduction of new components as well as concrete
implementation of standards. For example, DICOM 3
handles the general performance of image acquisition,
transfer and display in terms of basic rules [50]. However,
it cannot provide actual understanding of incorporated
devices in all conditions; the local specificities have to be
adjusted individually.
Table 1: Proposed levels of standards in tissue-based diagnosis
Level Legal aspects Medical aspects Technological aspects
1 (Highest, aims: what to do?) privacy, image documentation, 
transmission, presentation
disease – image combination, 
human, automated diagnosis, 
archive
Image display, formats, transfer 
speed, safety, system dynamics
2 (Intermediate, 
implementation: how to do?)
encryption of privacy data, 10 
years image archives, annotations 
of dates and viewing, precise 
hardware and software 
information
DICOM 3, HL 7, image resolution, 
fields of view, of sizes of biological 
objects and image access to 
archives and retrieval
PACS, image acquisition systems, 
image correction procedures, 
display resolution, image formats, 
storage, cycle frequency, backup 
procedures, operation system, 
external system accessibility
3 (Lowest, actual standard 
data: to do with what?)
Maximum error rate, individual 
prepositions, institutional 
characteristics.
Diagnosis frequencies, dates of 
continuous education, quality 
control.
Control check of devices and used 
systems, device and software 
maintenance.Diagnostic Pathology 2008, 3:17 http://www.diagnosticpathology.org/content/3/1/17
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The remaining workload in order to establish a wide
spread and detailed medical standard can be judged from
table 2. An univocal disease classification is the prerequi-
site for any additional steps in expanding medical stand-
ards. The WHO classification of tumours has to be
mentioned here, as well as the disease and cancer classifi-
cation schemes ICD-O and SNO-MED. However, no
investigations have been undertaken to refer these stand-
ards to disease-specific image characteristics to our knowl-
edge. Such standards would permit reproducible analysis
of virtual slides in relation to the stated diagnosis and, in
addition, quantify diagnostic accuracy and difficulty.
The hierarchic disease order as proposed by Mireskandari
et al. [41] grades the "distance" of an original stated diag-
nosis from that stated by the consulted expert. The pro-
posed error grading is shown in table 3.
Obviously, it is related to the clinical significance of med-
ical disagreement and fulfils the requirements of a stand-
ard measure in abbreviating medical diagnosis. Formal
disease nomenclature should be distinguished from the
classification of "disease meaning" which has to be stand-
ardized by intensive board discussions of the correspond-
ing specialists. The embedding of image acquisition,
handling, distribution, and display properties such as
DICOM 3, HL 7 try to combine medical demands with
technical tasks [43,29]. They are tools that have success-
fully replaced the conventional work flow in live imaging
[15,21,17,18]. The widely unknown expert communica-
tion guidelines have been derived from telepathology
experiences [6,2,3]. According to the data of open telepa-
thology systems such as iPATH or the UICC-TPCC, most
requesting pathologists fulfill these requirements without
knowing them. The mentioned standards to be applied
for virtual microscopy still wait for further development
and investigation. One should be aware of these items
when undertaking efforts to implement compartments of
digital pathology. Prerequisites to establish good per-
formance in virtual microscopy include the extraction of
object or texture related features from microscopic
images. They can ensure accurate diagnoses and avoid
remarkable errors [40].
Discussion
Anatomical surgical pathology or tissue-based diagnosis is
on its way to remarkably changing its working conditions
[61,62,39,63,29]. Viewing or analyzing microscopic
images will still remain the domain of diagnostic surgical
pathology; however, its technological procedures are
influenced by innovative developments of visual informa-
tion acquisition and distribution technology. Surgical
pathology presents with highly specialized visual medical
diagnostics that includes low costs and minimum error
rates. It possesses some similarities to live imaging tech-
niques such as CT, MR or ultrasound examinations. On
the other hand, it also remarkably differs from radiology.
The differences include formal and medical image proper-
ties, interactions with other medical disciplines such as
surgery or oncology, and specific laboratory technology.
Table 2: A survey of medical standards (level 2 and level 3) suggested or already implemented in tissue-based diagnosis
Medical Standard (level 2) Criteria (level 3) International/national Action
Disease order [41] Hierarchic, 1 – 10 Proposed
Formal disease classification ICD-O, SNO-MED Accepted
Disease/human classification Board discussion Accepted for tumours (WHO classification)
Disease frequency Not evaluated, probably >2 per month Open
Mandatory expert consultation Rare cancer, lymphoma Proposed
Mandatory quality assurance Breast cancer, Hodgkin's disease Accepted
Image handling, exchange by DICOM 3, HL 7 General & individual regulations Proposed
HIS, RIS communication by DICOM 3, HL 7 General & individual regulations Proposed
Expert communication guidelines 4 – 8 images/case, <2 different magnifications/case, Proposed
Virtual microscopy:
Diagnosis/image properties >50 pixels/object, >40 objects/image, >256 × 256 
image size
Proposed
Disease/image features Disease – associated texture, object, structure 
parameters
Open
Image quality measure Gray value deviation, image standardization (shading, 
gray value range, gradient)
Open
Screening/image size Texture features: crude screening Object/structure 
features: classical diagnosis (H&E)
Open
Diagnosis/colour space RGB space – classical diagnosis. HSI space – 
prognosis associated diagnosis, cancer scores 
(hormone receptor, Gleason, etc.)
OpenDiagnostic Pathology 2008, 3:17 http://www.diagnosticpathology.org/content/3/1/17
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Despite these differences, efforts have been undertaken to
implement aspects of standardization developed in radi-
ology to diagnostic pathology [43,29]. These efforts are
based upon the well known DICOM 3 and PACS stand-
ards, and promoted by experiences obtained from telepa-
thology, virtual microscopy, and Grid technology [39].
These technologies push the work flow of surgical pathol-
ogy to be integrated into so-called hospital information
systems (HIS), often in combination with a radiology
information system (RIS). The specific working condi-
tions of tissue-based diagnosis are difficult to understand
for HIS and RIS specialists, despite the fact that nearly all
institutes of pathology use pathology-specific documenta-
tion and archiving systems. This does not neglect the need
for automated patient registration data and tissue data
transfer from the HIS to the RIS or to apply HL7, an acro-
nym for Health Language 7 for these purposes. HL 7, a
standard text communication between different docu-
mentation systems, can be considered to be the DICOM
equivalent for these purposes. It includes, in addition, a
personal patient identification number which can be used
without changes to further identify the patient's tissue and
derived glass slides.
It seems appropriate to "grade" necessary or proposed
standards into hierarchic levels. These levels serve differ-
ent purposes: The first level describes the aims and pro-
posed actions of the standard. Three different items can be
distinguished in relation to the aim: legal, medical and
technological aspects. Legal items include the patient's
privacy as well as documentation prescriptions, image
labeling, or display performance. They should protect the
pathologist against inadequate diagnostic procedures,
such as diagnostic statements obtained from inadequate
images.
The term "medical standards" includes disease – related
issues that require specific attention in tissue-based diag-
nostics. For example, the diagnosis "carcinoma of the
lung" can be stated even when the quality of viewed glass
slides is not optimal in the majority of cases, in contrast to
the diagnosis of "usual interstitial pneumonia", which
requires high glass slide quality, specific knowledge by the
pathologist, and detailed clinical information
[22,64,65,3,4,66]. These specific medical conditions
become even more important when virtual microscopy
combined with artificial intelligence are applied.
The last aspect is of a technological nature. It includes the
technical prepositions to permit accurate diagnostic per-
formance as described by legal and medical aims. The res-
olution of display units has to be adjusted to the
requirements of medical performance as well as computa-
tion speed and image transfer time.
The second level regulates the implementation of the aims
formulated in the first level. It contains the usual descrip-
tors such as DICOM 3 or PACS. Most of the authors who
work on standard implementation specify the regulations
given at this level [43,50,66]. There are several working
groups analyzing the benefits and potential improve-
ments of DICOM 3 [50]; others try to enhance archive sys-
tems by changing details of PACS [30,67,44].
The lowest (third) level includes the actual limits of accu-
racy and allowed error rates. Medical conditions such as
minimum number of diagnosed specific diseases that are
mandatory to further diagnose the disease without expert
consultation are included as well. Technically, the actual
data of communicative and other digital standards are
noted within this level.
From the theoretical point of view, standards serve for a)
internal institutional and b) inter-institutional communi-
cation. They ensure a correct "understanding" between
different embedded devices and act, therefore, like a com-
mon language [6]. Internal institutional application pro-
vides a better self organization and is, in addition, an
appropriate tool to assure certain quality levels.
Table 3: Proposed error grading of potential medical differences between primary and expert diagnosis (according to [41].
Grade Error in Differences
0 Rejection or No answer
1 Organ tissue Normal <> Abnormal
2 Abnormal tissue Inflammatory <> Neoplastic
3 Lesion Acute <> Chronic; Benign <> Malignant
4 Cell type Sarcoma <> Carcinoma, Tumor <> Inflammation; Non- <> Invasive
5 Specificities Tbc; Fibroma <> Myoma; Adeno <> Squamous
6 Severity, Grading low <> high
7 Origin, bacteria Tbc <> Brucellosis; Primary <> Metastasis
8 Prognosis Good <> Fair <> Poor
9 Therapy, follow up No need <> yes
10 Identical diagnosis minor differences in differential diagnosisDiagnostic Pathology 2008, 3:17 http://www.diagnosticpathology.org/content/3/1/17
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In aggregate, implementation of legal, medical, and tech-
nological standards into routine tissue-based diagnosis is
an important issue in further developing this medical dis-
cipline. It still requires clearly defined statements for what
to do and for which purpose, statements that could be
classified, tested, and implemented according to the pro-
posed classification levels. The introduction of virtual
microscopy as well as combined AI to significantly sup-
port the efficiency, accuracy, and reputation of the pathol-
ogists' work demands new strategies in individual and
communicative actions and performance. We do hope
that this article will significantly promote pathologists'
understanding of the forthcoming changes, and that they
might steer and not just react to the unavoidable, however
also promising the so-called globalization or digital world
of future medicine.
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